Aging Clinical and Experimental Research
The efficacy of Sarcomeal® oral supplementation plus vitamin D3 on muscle parameters, metabolic factors, and quality of life in diabetic sarcopenia: a randomized controlled clinical trial
2025-03

Paper of the month "March 2025" - The efficacy of Sarcomeal® oral supplementation plus vitamin D3 on muscle parameters, metabolic factors, and quality of life in diabetic sarcopenia: a randomized controlled clinical trial

2025 MARCH

Dear Colleagues,

This paper has been selected as the March Aging Clinical and Experimental Research paper of the month (CLICK HERE). This paper shows that a nutritional intervention, associated to Vitamin D, can significantly improve different dimensions of SarQoL°. It is interesting to see that despite a mild to moderate effect on usual muscle parameters, this intervention has an effect on quality of life. This confirms that SarQoL° should be considered as an extremely sensitive and responsive tool for the assessment of intervention effects in sarcopenia

Kindest regards,

Professor Nicola Veronese
Editor-in-Chief of ACER

Professor Jean-Yves Reginster
Deputy Editor ACER